Marker Therapeutics Stock (NASDAQ: MRKR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 27.35K |
Day Range | - - - |
52 Wk Range | 2.40 - 6.16 |
Market Cap | $26.23M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 1.3% |
Days to Cover | 4.01 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Marker Therapeutics (NASDAQ:MRKR) through any online brokerage.
Other companies in Marker Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT), Geovax Labs (NASDAQ:GOVX) and Palatin Techs (AMEX:PTN).
Marker Therapeutics has a consensus price target of $6.00.
The stock price for Marker Therapeutics (NASDAQ: MRKR) is $2.94 last updated September 20, 2024 at 4:04 PM EDT.
There are no upcoming dividends for Marker Therapeutics.
Marker Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Marker Therapeutics.
Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.